methamphetamine has been researched along with Nervous System Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| De Luca, MA; Simola, N | 1 |
| Ceccatelli, S | 1 |
| Brooks, DM; Hutchinson, J; Kothiwal, AS; Poulsen, AJ; Poulsen, DJ; Rau, TF; Rhoderick, JF; Rova, AR | 1 |
| Donlon, M; Kelly, JP; McDonnell-Dowling, K | 1 |
| Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A | 1 |
| Kita, T; Nakashima, T; Wagner, GC | 1 |
| D'Astous, M; Di Paolo, T; Dluzen, DE; Gajjar, TM | 1 |
| de Almeida, SM; Ellis, RJ; Joseph, J | 1 |
| Booze, RM; Ferris, MJ; Mactutus, CF | 1 |
| Seiden, LS; Vosmer, G | 1 |
| Cadet, JL; Epstein, C; Hirata, H; Ladenheim, B; Rothman, RB | 1 |
| Koyama, T; Muraki, A; Ohmori, T; Yamashita, I | 1 |
| Stephans, SE; Yamamoto, BK | 1 |
| Sabol, KE; Seiden, LS | 1 |
| Eisch, AJ; Marshall, JF; O'Dell, SJ | 1 |
| Castañeda, E; Friedman, SD; Hodge, GK | 1 |
| Katz, JL; Ricaurte, GA; Steele, TD | 1 |
| Wagner, GC; Walsh, SL | 2 |
| Fuller, RW; Hemrick-Luecke, SK; Ornstein, PL | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Marshall, JF; O'Dell, SJ; Weihmuller, FB | 1 |
| Gibb, JW; Hanson, GR; Johnson, M | 1 |
| De Vito, MJ; Wagner, GC | 1 |
6 review(s) available for methamphetamine and Nervous System Disorders
| Article | Year |
|---|---|
Mechanisms of neurotoxicity and implications for neurological disorders.
Topics: Anti-HIV Agents; Central Nervous System Stimulants; Congresses as Topic; Hazardous Substances; Humans; Manganese; Methamphetamine; Nervous System Diseases; Neurotoxicity Syndromes; Neurotoxins; Parkinson Disease; Receptors, Dopamine; Risk Factors; Trace Elements | 2013 |
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents | 2010 |
Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.
Topics: Animals; Biogenic Monoamines; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Oxidative Stress; Research Design | 2003 |
NeuroAIDS in Brazil.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Animals; Anti-Retroviral Agents; Brain; Brazil; Central Nervous System Stimulants; Cognition; Cognition Disorders; Comorbidity; Congresses as Topic; Developing Countries; Drug Resistance, Viral; Genetic Variation; Global Health; Government Programs; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Methamphetamine; Nervous System Diseases; Neuropsychological Tests; Somatostatin | 2007 |
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.
Topics: Animals; Brain; Cocaine; Dopamine; HIV; HIV Infections; Humans; Methamphetamine; Nervous System Diseases; Neural Pathways; Neurotoxicity Syndromes; Neurotoxins; Substance-Related Disorders | 2008 |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
Topics: Animals; Central Nervous System Stimulants; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats | 1996 |
18 other study(ies) available for methamphetamine and Nervous System Disorders
| Article | Year |
|---|---|
Editorial of special issue - Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects.
Topics: Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Psychotropic Drugs; Treatment Outcome | 2022 |
Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats.
Topics: Animals; Brain Injuries; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Humans; Male; Maze Learning; Methamphetamine; Nervous System Diseases; Neurofilament Proteins; Neurons; Rats; Rats, Wistar; Space Perception; Time Factors | 2014 |
Methamphetamine exposure during pregnancy at pharmacological doses produces neurodevelopmental and behavioural effects in rat offspring.
Topics: Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Female; Male; Mental Disorders; Methamphetamine; Nervous System Diseases; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 2014 |
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Interactions; Estradiol; Female; In Situ Hybridization; Iodine Isotopes; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neostriatum; Nerve Tissue Proteins; Nervous System Diseases; Neuroprotective Agents; Ovariectomy; Protein Binding; RNA, Messenger; Substantia Nigra; Time Factors | 2004 |
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydroxydopamines; Male; Methamphetamine; Nervous System Diseases; Oxidopamine; Rats; Rats, Inbred Strains | 1984 |
Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals.
Topics: Animals; Autoradiography; Brain; Free Radicals; Male; Methamphetamine; Mice; Mice, Transgenic; Nervous System Diseases; Presynaptic Terminals; Serotonin; Superoxide Dismutase | 1995 |
Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dizocilpine Maleate; Dopamine; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methylaspartate; Nervous System Diseases; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin | 1993 |
Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
Topics: Animals; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Extracellular Space; Glutamic Acid; Haloperidol; Male; Methamphetamine; Microdialysis; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley | 1994 |
Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine.
Topics: Animals; Autoradiography; Carrier Proteins; Caudate Nucleus; Cerebral Cortex; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glutamic Acid; Image Processing, Computer-Assisted; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Nervous System Diseases; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1996 |
Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Central Nervous System Stimulants; Male; Maze Learning; Methamphetamine; Nervous System Diseases; Orientation; Psychomotor Performance; Rats | 1998 |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship | 1992 |
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
Topics: Animals; Avoidance Learning; Disease Models, Animal; Dopamine; Fenfluramine; Levodopa; Male; Methamphetamine; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Serotonin | 1992 |
Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
Topics: Amino Acids; Amphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Iprindole; Isoquinolines; Male; Methamphetamine; Mice; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Male; Methamphetamine; Nervous System Diseases; Putamen; Rats; Rats, Inbred Strains | 1991 |
Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
Topics: Aging; Animals; Clorgyline; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nervous System Diseases; Neurons; Selegiline | 1991 |
Neurochemical basis of neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Monoamines; Designer Drugs; Dopamine; Glutamates; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Nervous System Diseases; Serotonin | 1990 |
Functional consequences following methamphetamine-induced neuronal damage.
Topics: Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drinking; Male; Methamphetamine; Nervous System Diseases; Rats; Rats, Inbred Strains; Serotonin | 1989 |